We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.8B
AUM Growth
-$180M
Cap. Flow
-$262M
Cap. Flow %
-6.89%
Top 10 Hldgs %
17.53%
Holding
781
New
342
Increased
77
Reduced
104
Closed
239

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$71.1M
2
ARMK icon
Aramark
ARMK
+$57.7M
3
BA icon
Boeing
BA
+$46.8M
4
EBAY icon
eBay
EBAY
+$46.2M
5
ITGR icon
Integer Holdings
ITGR
+$41.2M

Sector Composition

Rank Sector Weight
1 Industrials 14.07%
2 Consumer Discretionary 12.1%
3 Technology 10.49%
4 Healthcare 7.89%
5 Financials 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIV
551
Aimco
AIV
$387M
-343,088
Closed -$2.05M
AKRO
552
CALL
DELISTED
Akero Therapeutics
AKRO
-13,600
Closed -$646K
ALNY icon
553
PUT
Alnylam Pharmaceuticals
ALNY
$29.5B
-6,800
Closed -$3.1M
AMC icon
554
CALL
AMC Entertainment Holdings
AMC
$2.54B
-870,300
Closed -$2.52M
AMGN icon
555
PUT
Amgen
AMGN
$204B
-10,000
Closed -$2.82M
AMPL icon
556
PUT
Amplitude
AMPL
$1.26B
-621,600
Closed -$6.66M
AMT icon
557
PUT
American Tower
AMT
$80.6B
-26,300
Closed -$5.06M
ANGI icon
558
CALL
Angi Inc
ANGI
$240M
-660,000
Closed -$10.7M
ARCT icon
559
CALL
Arcturus Therapeutics
ARCT
$171M
-105,000
Closed -$1.94M
ARCT icon
560
Arcturus Therapeutics
ARCT
$171M
-22,118
Closed -$408K
ARDX icon
561
CALL
Ardelyx
ARDX
$1.23B
-52,500
Closed -$289K
ARKK icon
562
ARK Innovation ETF
ARKK
$5.84B
-33,507
Closed -$2.89M
ARKQ icon
563
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.95B
-4,000
Closed -$446K
ARQT icon
564
Arcutis Biotherapeutics
ARQT
$3.24B
-353,644
Closed -$6.67M
ASO icon
565
Academy Sports + Outdoors
ASO
$3.01B
-98,632
Closed -$4.89M
ASTL icon
566
CALL
Algoma Steel
ASTL
$413M
-161,800
Closed -$575K
ASTL icon
567
Algoma Steel
ASTL
$413M
-2,263,011
Closed -$8.05M
AUPH icon
568
Aurinia Pharmaceuticals
AUPH
$1.87B
-13,500
Closed -$149K
AUPH icon
569
PUT
Aurinia Pharmaceuticals
AUPH
$1.87B
-40,500
Closed -$448K
AVDL
570
DELISTED
Avadel Pharmaceuticals
AVDL
-94,867
Closed -$1.45M
AXP icon
571
American Express
AXP
$233B
-23,327
Closed -$7.75M
AXSM icon
572
Axsome Therapeutics
AXSM
$10.9B
-8,401
Closed -$1.17M
AZN icon
573
PUT
AstraZeneca
AZN
$245B
-150
Closed -$23K
BG icon
574
CALL
Bunge Global
BG
$20.2B
-105,000
Closed -$8.53M
BG icon
575
Bunge Global
BG
$20.2B
-171,575
Closed -$13.9M

Similar funds

J. Goldman & Co's Q4 2025 Portfolio in Review

As of Q4 2025, J. Goldman & Co held 781 positions worth $3.8B, down 4.5% from $3.98B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

J. Goldman & Co withdrew a net $262M in Q4 2025, closing 239 positions and reducing 104 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $74.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, J. Goldman & Co opened a new position in Honeywell worth $70.9M.

  • J. Goldman & Co's largest Q4 2025 buy was Honeywell: 363,411 shares worth $70.9M.
  • J. Goldman & Co added most to eBay in Q4 2025, an estimated $46.2M increase.
  • J. Goldman & Co's biggest Q4 2025 reduction was Globus Medical, cutting an estimated $61.8M.
  • J. Goldman & Co fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $74.4M.
  • J. Goldman & Co's ten largest holdings make up 18% of its $3.8B portfolio in Q4 2025.
  • J. Goldman & Co opened 342 new positions and closed 239 in Q4 2025.
  • J. Goldman & Co's portfolio value fell 4.5% quarter-over-quarter to $3.8B.

Based on J. Goldman & Co's 13F filing for Q4 2025, filed 17 Feb 2026.